Etkin Amit has filed 16 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 6227 shares of Alto Neuroscience, Inc. ($ANRO) on March 01, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | F | Common Stock | 6227 | $19.69 | 1,233,949.0000 | 31,066,335 | 0.50% | 0.02% |
| Feb. 11, 2026 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 306000 | $0.00 | 306,000.0000 | 31,066,335 | 9999.99% | 0.98% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 247290 | $0.00 | 247,290.0000 | 27,072,129 | 9999.99% | 0.91% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 247290 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.91% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 223000 | $0.00 | 223,000.0000 | 27,072,129 | 9999.99% | 0.82% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 223000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.82% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 27,072,129 | 9999.99% | 0.79% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 215000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.79% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 34620 | $0.00 | 34,620.0000 | 27,072,129 | 9999.99% | 0.13% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 34620 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.13% |
| Feb. 5, 2025 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 223000 | $0.00 | 223,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | A | Common Stock | 34711 | $0.00 | 1,240,176.0000 | 0 | 2.88% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | C | Common Stock | 11777 | $0.00 | 1,202,340.0000 | 0 | 0.99% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | P | Common Stock | 3125 | $16.00 | 1,205,465.0000 | 0 | 0.26% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Etkin Amit | PRESIDENT AND CEO | C | Series B Preferred Stock | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |